1
|
Prediction of peptide retention at different HPLC conditions from multiple linear regression models.
|
J Proteome Res
|
2005
|
0.93
|
2
|
Comparative characteristics of HPLC columns based on quantitative structure-retention relationships (QSRR) and hydrophobic-subtraction model.
|
J Chromatogr A
|
2005
|
0.91
|
3
|
Reversed-phase TLC and HPLC retention data in correlation studies with in silico molecular descriptors and druglikeness properties of newly synthesized anticonvulsant succinimide derivatives.
|
Mol Pharm
|
2011
|
0.89
|
4
|
Simultaneous determination of pKa and lipophilicity by gradient RP HPLC.
|
Anal Chem
|
2006
|
0.87
|
5
|
Predictions of peptides' retention times in reversed-phase liquid chromatography as a new supportive tool to improve protein identification in proteomics.
|
Proteomics
|
2009
|
0.86
|
6
|
Determination of pKa by pH gradient reversed-phase HPLC.
|
Anal Chem
|
2004
|
0.86
|
7
|
Electrochemical impedance spectroscopy for study of amyloid beta-peptide interactions with (-) nicotine ditartrate and (-) cotinine.
|
Biosens Bioelectron
|
2006
|
0.86
|
8
|
Comparative evaluation of high-performance liquid chromatography stationary phases used for the separation of peptides in terms of quantitative structure-retention relationships.
|
J Chromatogr A
|
2007
|
0.85
|
9
|
Artificial neural network analysis for evaluation of peptide MS/MS spectra in proteomics.
|
Anal Chem
|
2004
|
0.83
|
10
|
The state-of-the-art determination of urinary nucleosides using chromatographic techniques "hyphenated" with advanced bioinformatic methods.
|
Anal Bioanal Chem
|
2011
|
0.83
|
11
|
Liquid chromatography tandem mass spectrometry study of urinary nucleosides as potential cancer markers.
|
J Chromatogr A
|
2013
|
0.83
|
12
|
Chromatographic retention parameters in medicinal chemistry and molecular pharmacology.
|
Curr Med Chem
|
2003
|
0.82
|
13
|
The application of gradient reversed-phase high-performance liquid chromatography to the pK(a) and log k(w) determination of polyprotic analytes.
|
J Chromatogr A
|
2008
|
0.82
|
14
|
Quantitative structure-retention relationships in affinity high-performance liquid chromatography.
|
J Chromatogr B Analyt Technol Biomed Life Sci
|
2002
|
0.81
|
15
|
Pharmacokinetics and pharmacodynamics of propofol in patients undergoing abdominal aortic surgery.
|
Pharmacol Rep
|
2012
|
0.81
|
16
|
Development and validation of urinary nucleosides and creatinine assay by capillary electrophoresis with solid phase extraction.
|
J Pharm Biomed Anal
|
2007
|
0.80
|
17
|
Association constants of pyridine and piperidine alkaloids to amyloid beta peptide determined by electrochemical impedance spectroscopy.
|
Curr Alzheimer Res
|
2010
|
0.80
|
18
|
pH/organic solvent double-gradient reversed-phase HPLC.
|
Anal Chem
|
2005
|
0.80
|
19
|
The quantification of reticulocyte maturation and neocytolysis in normal and erythropoietin stimulated rats.
|
Biopharm Drug Dispos
|
2014
|
0.80
|
20
|
Micellar liquid chromatography for lipophilicity determination of new biologically active 1,3-purinodiones.
|
J Sep Sci
|
2010
|
0.79
|
21
|
Predictive approaches to gradient retention based on analyte structural descriptors from calculation chemistry.
|
J Chromatogr A
|
2003
|
0.79
|
22
|
New supervised alignment method as a preprocessing tool for chromatographic data in metabolomic studies.
|
J Chromatogr A
|
2012
|
0.79
|
23
|
Altered levels of nucleoside metabolite profiles in urogenital tract cancer measured by capillary electrophoresis.
|
J Pharm Biomed Anal
|
2010
|
0.79
|
24
|
Metabolomic approach for determination of urinary nucleosides as potential tumor markers using electromigration techniques.
|
Electrophoresis
|
2010
|
0.79
|
25
|
Combination of linear solvent strength model and quantitative structure-retention relationships as a comprehensive procedure of approximate prediction of retention in gradient liquid chromatography.
|
J Chromatogr A
|
2002
|
0.78
|
26
|
Quantitative structure-retention relationships models for prediction of high performance liquid chromatography retention time of small molecules: endogenous metabolites and banned compounds.
|
Anal Chim Acta
|
2013
|
0.78
|
27
|
Assessing circadian rhythms during prolonged midazolam infusion in the pediatric intensive care unit (PICU) children.
|
Pharmacol Rep
|
2013
|
0.78
|
28
|
pH gradient reversed-phase liquid chromatography as a fractionation tool for the separation of peptides.
|
Talanta
|
2007
|
0.78
|
29
|
Efficient recovery of electrophoretic profiles of nucleoside metabolites from urine samples by multivariate curve resolution.
|
Electrophoresis
|
2009
|
0.78
|
30
|
Correctness of protein identifications of Bacillus subtilis proteome with the indication on potential false positive peptides supported by predictions of their retention times.
|
J Biomed Biotechnol
|
2009
|
0.78
|
31
|
Verification of the exponential model of body temperature decrease after death in pigs.
|
Exp Physiol
|
2005
|
0.77
|
32
|
Amlodipine increased endothelial nitric oxide and decreased nitroxidative stress disproportionately to blood pressure changes.
|
Am J Hypertens
|
2013
|
0.77
|
33
|
Chromatographic retention parameters in correlation analysis with in silico biological descriptors of a novel series of N-phenyl-3-methyl succinimide derivatives.
|
J Pharm Biomed Anal
|
2012
|
0.77
|
34
|
Comparison of RP-HPLC columns used for determination of nucleoside metabolic patterns in urine of cancer patients.
|
Bioanalysis
|
2012
|
0.77
|
35
|
Evaluation of the silanol-suppressing potency of ionic liquids.
|
J Sep Sci
|
2006
|
0.77
|
36
|
Evaluation of a generalized use of the log Sum(k+1)AA descriptor in a QSRR model to predict peptide retention on RPLC systems.
|
J Sep Sci
|
2009
|
0.77
|
37
|
Mydriasis model in rats as a simple system to evaluate α2-adrenergic activity of the imidazol(in)e compounds.
|
Pharmacol Rep
|
2013
|
0.76
|
38
|
Imidazoline receptors in relaxation of acetylcholine-constricted isolated rat jejunum.
|
Pharmacol Rep
|
2006
|
0.76
|
39
|
Quantitative structure-activity relationships study of a series of imidazole derivatives as potential new antifungal drugs.
|
Acta Pol Pharm
|
2002
|
0.76
|
40
|
Human red blood cells targeted metabolome analysis of glycolysis cycle metabolites by capillary electrophoresis using an indirect photometric detection method.
|
J Pharm Biomed Anal
|
2005
|
0.76
|
41
|
The application of 19F magnetic resonance ex vivo imaging of three-dimensional cultured breast cancer cells to study the effect of delta-tocopherol.
|
Anal Biochem
|
2009
|
0.76
|
42
|
Determination of ascorbic acid and its degradation products by high-performance liquid chromatography-triple quadrupole mass spectrometry.
|
Electrophoresis
|
2014
|
0.76
|
43
|
Partial least square and hierarchical clustering in ADMET modeling: prediction of blood-brain barrier permeation of α-adrenergic and imidazoline receptor ligands.
|
J Pharm Pharm Sci
|
2013
|
0.76
|
44
|
Pharmacokinetics and pharmacodynamics of propofol in cancer patients undergoing major lung surgery.
|
J Pharmacokinet Pharmacodyn
|
2015
|
0.75
|
45
|
19F MRI of 3D CEM cells to study the effects of tocopherols and tocotrienols.
|
J Pharm Biomed Anal
|
2010
|
0.75
|
46
|
A new pH/organic modifier gradient RP HPLC method for convenient determination of lipophilicity and acidity of drugs as applied to established imidazoline agents.
|
Eur J Pharm Sci
|
2012
|
0.75
|
47
|
Retention time and peak width in the combined pH/organic modifier gradient high performance liquid chromatography.
|
J Chromatogr A
|
2010
|
0.75
|
48
|
Steroid profiles as potential biomarkers in patients with urogenital tract cancer for diagnostic investigations analyzed by liquid chromatography coupled to mass spectrometry.
|
J Pharm Biomed Anal
|
2012
|
0.75
|
49
|
Using bioanalysis for cancer diagnosis and prognosis.
|
Bioanalysis
|
2014
|
0.75
|
50
|
Magnetic beads method for determination of binding of drugs to melanin.
|
J Chromatogr A
|
2010
|
0.75
|
51
|
Combined pH/organic solvent gradient HPLC in analysis of forensic material.
|
J Pharm Biomed Anal
|
2005
|
0.75
|
52
|
Influence of pH on retention in linear organic modifier gradient RP HPLC.
|
Anal Chem
|
2008
|
0.75
|
53
|
Behavior of peptides and computer-assisted optimization of peptides separations in a normal-phase thin-layer chromatography system with and without the addition of ionic liquid in the eluent.
|
Biomed Chromatogr
|
2005
|
0.75
|
54
|
Ionic liquids as mobile phase additives for feasible assay of naphazoline in pharmaceutical formulation by HPTLC-UV-densitometric method.
|
J Chromatogr Sci
|
2012
|
0.75
|
55
|
Quantitative structure-retention relationships in comparative studies of behavior of stationary phases under high-performance liquid chromatography and capillary electrochromatography conditions.
|
J Chromatogr A
|
2002
|
0.75
|
56
|
pH Gradient as a tool for the separation of ionizable analytes in reversed-phase high-performance chromatography.
|
Anal Chem
|
2010
|
0.75
|
57
|
High-throughput evaluation of lipophilicity and acidity by new gradient HPLC methods.
|
Comb Chem High Throughput Screen
|
2004
|
0.75
|
58
|
Development and validation of UHPLC method for the determination of cyclosporine A in biological samples.
|
Biomed Chromatogr
|
2014
|
0.75
|
59
|
pH-Gradient Liquid Chromatography: Fundamentals and Examples.
|
J AOAC Int
|
2017
|
0.75
|
60
|
Artificial neural networks for prediction of antibacterial activity in series of imidazole derivatives.
|
Comb Chem High Throughput Screen
|
2004
|
0.75
|
61
|
Advanced assessment of the endogenous hormone level as a potential biomarker of the urogenital tract cancer.
|
Comb Chem High Throughput Screen
|
2013
|
0.75
|
62
|
Evaluation of different warping methods for the analysis of CE profiles of urinary nucleosides.
|
Electrophoresis
|
2007
|
0.75
|
63
|
Reversed- and normal-phase liquid chromatography in quantitative structure retention-property relationships of newly synthesized seco-androstene derivatives.
|
J Pharm Biomed Anal
|
2013
|
0.75
|
64
|
Separation of nicotinic acid and its structural isomers using 1-ethyl-3-methylimidazolium ionic liquid as a buffer additive by capillary electrophoresis.
|
J Pharm Biomed Anal
|
2005
|
0.75
|